Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

UK Government Sets Recommendations for Sugar Reduction in Food Industry



The hope is that these sugar limits will help young people achieve a five percent reduction in their sugar intake in the next year, with a total 20 percent reduction in the next three years.

Share this!

March 31, 2017 | by Sarah Hand, M.Sc.

The UK government agency, Public Health England (PHE) has released voluntary guidelines aimed at reducing children’s sugar intake by the year 2020. The hope is that these sugar limits will help young people achieve a five percent reduction in their sugar intake in the next year, with a total 20 percent reduction in the next three years.

The recommended sugar limits will affect nine different categories of food, including biscuits, cereals, chocolate and ice cream, which have been shown to contribute most to sugar intake. The PHE also stipulates that the reduction in sugar should not be compensated for by an increase in saturated fat, and the government body is also looking for reduced calorie products.

According to Alison Cox, Cancer Research UK’s Director for Cancer Prevention, excess sugar consumption has been associated with an increased risk of obesity. In turn, obesity can increase a person’s risk of developing cancer as they age.

“Without action, the problem is only going to get worse, so it’s vital this new program works towards the goal of slashing the amount of sugar hidden in our food,” said Cox. “But this won’t happen unless the food industry acts now to meet these targets.”

In addition to recommending that the food industry lower sugar levels in products – especially those aimed at children – PHE says portion sizes should be cut down. They also recommend that consumers be encouraged to buy lower sugar/no added sugar food products.

“If industry can’t make this work, the NHS will struggle to deal with the obesity crisis we’re hurtling towards,” said Cox. “But this doesn’t have to be the case and we can’t afford to get this wrong. We hope to see companies cutting down on sugar and portion sizes over the coming years to play their part in improving our health.”

According to the PHE guidance document, overconsumption of sugar in the UK has contributed to obesity, tooth decay and other health problems. Along with leading to poorer health outcomes for citizens, excessive sugar consumption also places a substantial economic burden on the NHS.

“Overweight and obese children are likely to carry this health problem into adulthood, increasing their risk of type 2 diabetes, heart disease and some cancers,” said PHE’s chief nutritionist, Dr. Alison Tedstone. “Levels of obesity are higher in children from deprived backgrounds. Tackling the amount of sugar we eat is not just a healthy thing to do, but an issue of inequality for many families.”

Keywords:  Added Sugars, Food Industry, Obesity


Share this with your colleagues!

Kite Pharma Secures FDA Approval for CAR-T Immunotherapy

October 20, 2017 - Kite Pharma’s Yescarta (axicabtagene ciloleucel) has become the second CAR-T immunotherapy to be approved in the US, with an indication in treating adult patients with relapsed or refractory large B-cell lymphoma.

Featured In: Biotech News

Fallopian Tubes Found to be Site of Origin for Most Ovarian Cancers

October 20, 2017 - This year, over 22,000 women will be diagnosed with ovarian cancer but a new study conducted by researchers at Perlmutter Cancer Center at NYU Langone Health suggests that most of these malignancies begin in another part of the reproductive system: the fallopian tubes.

Featured In: Life Science News

Food Companies are Looking for the Next Sriracha

October 19, 2017 - The Sriracha trend might be coming to an end and companies are looking for the next big hot sauce star to feature in their line-up.

Featured In: Food News


Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub


Brexit – Separating Fact from Fiction

Evolving Best Practices for Working with Authors of Scientific Publications – Authorship and Beyond

Human Whole-Genome Sequencing in a New Era Defined by the Illumina® HiSeq X® and NovaSeq™ Platforms

Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution

Copyright © 2016-2017 Honeycomb Worldwide Inc.